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More than 25 years after the atomic bombings of the Japanese cities of Hiro-
shima and Nagasaki, the late effects of radiation on the health of the survivors
are still incompletely known. However, the Atomic Bomb Casualty Commission
(ABCC) continues to monitor moribidity and mortality of A-bomb survivors.
The ABCC is a binational endeavor; the parent organizations are the U.S. Na-
tional Academy of Sciences-National Research Council (NAS-NRC) and the Japa-
nese National Institute of Health (JNIH) of the Ministry of Health and Welfare
(1). The late R. Keith Cannan, who, for many years, as Chairman of the Division
of Medical Sciences of the NAS-NRC, had general responsibility for ABCC on
the U.S. side, has reviewed the history of the Commission (2). Miller (3) has
summarized the major findings as to delayed radiation effects. Dr. James Hollings-
worth (1) reviewed the major findings from 1948-1959. The present report con-
cerns the following decade (1958-1968) during which a new study plan was put
into effect. In the late 1950's, ABCC completed the organization of a program
based on a revised study cohort designed to permit large-scale epidemiologic
studies on the effects of sublethal whole-body radiation. The cohort selection was
based on a Special Survey of A-bomb Survivors made in 1950. In brief, nonir-
radiated, distally located survivors as well as subjects not present in the cities at
the time of the bomb were matched by age and sex with survivors who sustained
variable amounts of radiation. Selection and characterization are described in detail
elsewhere (4-6).
1 Supported by U.S.A. Atomic Energy Commission, Japanese National Institute of Health,
and U.S.A. Environmental Protection Agency.
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THE POPULATION
All persons, in both cities, verified to have been within 2000 m of the bursts,
were chosen for study. To these were matched, by age and sex, a group whose
members were in the environs but at distances. where there was little or no radiation
(3000-3499 m in Hiroshima and 3000-3999 m in Nagasaki) and a nonirradiated
control group which was not present within the cities at the time of the bombing
(ATB). The final study population of 109,000 persons, including survivors and
control subjects (Life Span Study population) is followed for mortality at the level
of the death certificate. A subsample (originally numbering about 20,000 in 1950),
has undergone biennial physical examinations since 1958 (the Adult Health
Study-AHS). The programs of study of these populations have been formally ap-
proved by the governments of Japan and the United States.
Within the framework of the Adult Health Study program, which is the basis
for the present report, the numbers of subjects (minus those deceased or who
moved out of the cities) of the first and fifth 2-year examination intervals, or cycles,
are shown in Table 1 by estimated A-bomb radiation dose (see below), sex, and
city. The fraction of each original subgroup who continued to return for clinical
examinations is shown for Cycle 1 (1958-1960) and Cycle 5 (1966-1968) in
Table 2. Figures for the intervening periods are intermediate between those shown.
It can be seen in the tables that a great majority of subjects living in the city re-
turned for examinations over the decade from 1958-1968. Those more heavily ir-
radiated participated slightly more, but the difference between this group and the
nonexposed was very small.
TABLE 1
ADULT HEALTII STUDY, NUMBER OF SUBJECTS (MID-CYCLE)
Hirosshima Nagasaki
Estimated radiaiton lstimated. radiation
D)ose. Radh Dose. Radb
Cycle 'I'otal NICa 0-9 10-99 100+ Total NICa 0-9 10-99 100+
M1ale
1958-1960 4719 19206 153.5 1043 730 95927 636 657 311 698
1966-1968 4149 106;5 1366 897 637 9.314 5892 (09 980 567
Female
1958-1960 7991 2039 2558 9119 981 3369 851 916 421 815
1966-1968 7437 1910 2402 19392 9)0 3930 806 889) 397 781
a Not in the city at time of bombing.
b Total estimated radiation dose in rad (10),
TABLE -'
PERCENTAGE OF PARtTICIIPATION IN EXAMINArIONS
Hiro- Naga-
Class Cycle Total MNale Female shima saki NICa 0-9 Rad 10+ Rad
Total sample 1958-60 74.8 71.9 76.7 75.8 72.6 72.8 74.6 76.3
1966-68 63.4 58.2 66.9 64.5 61.1 60.6 64.5 64.9
Total sample 1958-60 80.4 79.3 81.1 81.9 77.2 76.6 80.4 82.6
Minus deceased 1966-68 74.3 72.0 75.6 76.6 69.3 69.9 75.3 76.1
Total sample 1958-60 89.9 89.2 88.9 88.5 90.1 87.3 87.9 90.6
Living in city 1966-68 85.3 84.7 85.7 85.0 86.3 83 9 85. 6 86.0
a Not in the city at the time of bombinig,
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CLINIC PROCEDURES AND THE CULTURAL MILIEU
The clinical examination reflects traditional patterns of recorded histories and
physical findings on standard forms. Laboratory tests on bloed, urine, and stool,
as well as chest films, are also obtained at each biennial visit. Any necessary further
tests and observations are performed on follow-up clinic visits.
It is important to emphasize that all clinic subjects are examined without overt
knowledge of their radiation status. However, it would be naive to suggest there
is no observational bias. For various reasons, an individual survivor could readily
inform the ABCC clinic physician, a Japanese doctor, that, for instance, his "back
discomfort" was present since the bombing. In addition, as recorded material ac-
cumulated, chart review could suggest evidence that the subject might be a survivor
of the atomic bombing.
The population is fixed, and accountability for every member is important. For
those too ill to attend the clinics, there is a home visit program. Periodic checks
on the subject's koseki ( a local vital statistics register unique to Japan), and noti-
fication of death in each instance serve additionally to ensure data on each
participant.
The examinations must be viewed within the indigenous cultural milieu that
ABCC has worked since 1947. Since these examinations are voluntary, what influ-
ences over 85% of those eligible to continue to return every other year for their
"check up" is not completely known. Certainly, the nonexposed control subjects
must know that their "A-bomb disease" potential is nil.
Many feel that the "American" examination is more beneficial, even though vir-
tually all clinical procedures are carried out by Japanese physicians. A hopefully
normal report, traditional participation in group activities, willingness to contribute
to the research endeavor, satisfaction with the clinic routine, acceptance of ABCC
as an integral part of the community, and probably other factors, also apply.
DOSE ESTIMATION FOR A-BOMB SURVIVORS
In analyses before 1966, intensity of sublethal atomic bomb radiation received
by survivors was measured only by distance from the detonation area. Studies (7,
8) since that time have resulted in individual total dose assignments (9) to virtually
the entire cohort.
Thus, atomic bomb doses in rad (the simple sum of gamma plus first collision
neutrons) can be used to map a continuous dose effect, judge thresholds for special
observations, and yield data in forms relevant to current discussion. Nevertheless,
these figures are recognized to be estimated values. The degree of inexactness is
not known, but may be as high as 30% (10). Table 3 lists mean gamma and
TABLE 3
ESTIMATED MEAN Aiit 1)osIE (RAD) FOIR SELECTED DISTANCES FIROM THE IHYPOCENTERa
Ilijioshiniia Nagasaki
Distanlce ___________ _____ ______ ___________________
(meters) Gamilma Neutironi Total G(amnima NeutroIn Total
600-649 1443 1465 2908 4415 370 4785
1000-1049 219 160 379 784 30 814
1500-1549 19 8 927 102 1 103
92000-2049 1.9 0 1.9 <2(0 0 <20
a Adapted from 'Milton aIl(l Sholoji (10).
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neutron doses for selected distances from the hypocenter, a landmark directly be-
neath the point of explosion. The table emphasizes two important considerations:
in Hiroshima the neutron component was greater, while at similar distances from
the hypocenter the intensity of total radiation (gamma plus neutron) was greater
in Nagasaki.
The major effort of the biennial examinations of the Adult Health Study is to
judge, via periodic clinical appraisal of large numbers, the general health of the
population. It is important to note that this serves especially to identify trends that
can be pursued in greater detail.
In combination, detailed studies and regular examinations provide insights not
only into some effects associated with A-bomb radiation, but also health (disease)
trends over time, and permit age, sex, and intercity comparisons. The following
sections attempt to review only some of these aspects. Age is given as that at the
time of the bomb in recognition of possible different biologic responses to radia-
tion at different periods of growth and development.
LATE RADIATION EFFECTS
Analysis of the results of the regular biennial examinations over Cycles 1-5
(1958-68) (11) revealed that, at this level, there were no significant uniform
differences between heavily irradiated, lightly irradiated, and control subjects ex-
cept for diseases of the thyroid gland and of the eye.
This is not unexpected in the clinic population of about 16,000 followed for
10 years and in which only one-half were exposed to variable doses of total body
radiation. The numbers of survivors and controls are too small to generate sufficient
numbers of specific conditions or diseases for analysis. The clinical examinations
were carried out by a large number of different physicians over the decade under
consideration. When this group was studied by death certificates from 1950 (the
date of establishment of the cohort) or by a researcher trained in a special aspect,
radiation-related effects were noted.
Cancer in general (12), and leukemia (13) and thyroid cancer (14, 15) in
particular, have been shown in other studies to be more prevalent among heavily
irradiated A-bomb survivors. In addition, persons heavily exposed appear to be
at greater risk of cancer of the breast (16), lung (17), and salivary glands (18).
Increased cancer risk has been most recently evident in those exposed when they
were less than 10 years old (19).
DISEASES OF THE THYROID
This category includes all thyroid diseases except cancer. In females of all ages
at the time of the bomb in Hiroshima, and in those less than 20 years of age ATB
in Nagasaki, the prevalence of thyroid diseases rises with dose. Figure 1 shows
this for females in the fifth cycle (1966-1968). The number for males is too small
to yield meaningful rates, but the data (not given here) from the 2-year examina-
tions (1 ) suggest a possible radiation relationship also.
Simple and nontoxic nodular goiters constitute approximately 75% of the diag-
noses. The remainder include thyroiditis and disorders of thyroid function in about
equal proportions.
During observations over 16 months in 1958-1959, Hollingsworth et al. (20)
examined more than 5000 subjects of the AHS in Hiroshima. They found that
simple nontoxic goiters were predominant among thyroid disorders. Nedules and
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FIG. 1. Prevalence of diseases of the thyroid, fifth examination cycle, by radiation dose
and city for females age 0-19 ATB.
hyperthyroidism were more frequent in the group proximal to the hypocenter. Al-
though these investigators were cautious in ascribing these findings to radiation
from the atomic bombs, the persistence of these trends in Hiroshima females
throughout the five cycles makes these observations even more convincing. More-
over, in Nagasaki, where a special study was not undertaken, radiation-related thy-
roid disease is also seen, especially for females who were young when irradiated.
Radiation effects may be more readily noted in subjects with dietary (goitrogen)
or genetic disposition to hyperplasia of the thyroid gland, but data on these points
are not available. Radioactive fallout, specifically iodide nuclides, is not considered
to be a factor, city wide (21), but the possibility of radiation-induced or augmented
hypothyroidism cannot be ruled out in view of studies of Marshall Islanders (22).
Studies in process will measure serum thyroid-stimulating hormone levels in a fur-
ther effort to assess thyroid function in A-bomb survivors. During 1962-1963, tests
(unpublished) of thyroid function and antibodies in more than 1000 subjects did
not show significant differences between exposed and nonexposed groups.
DISEASES OF THE EYE
This is a heterogeneous group of diagnoses made during the screening examina-
tions and influenced by many short-term intensive investigations. For the entire
group examined, average prevalence rates increased generally with A-bomb radia-
tion dose.
In Hiroshima the radiation relationship was statistically stronger than in Naga-
saki. Among Hiroshima females, prevalence increased significantly with dose for
those aged 0-19 ATB in each cycle except the third; for those aged 20-29 ATB
in the second, third, and fifth cycles; and for those aged 40-49 ATB in the second
and fourth cycles. For males aged 0-19 ATB, a significantly increased prevalence
of disease was notable in the first and second cycles.
Younger persons ATB may have been the most sensitive to radiation-associated
eye conditions (Fig. 2). Also, Miller (23) has reported more refractive errors
among proximally exposed children compared with those more distant from the
detonation. However, the conclusions based on the cycle examination data cannot
necessarily be taken to apply to every particular eye condition in this group. The
irregularities in the association of disease with radiation among age, city, or sex
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FIG. 2. Prevalence of diseases of eye, fifth examination cycle, by radiation dose and
sex for Hiroshima, age 0-19 ATB.
groups may be attributable, in part, to the many different observers associated with
prior cataract substudies (24-31).
Of the group of eye conditions discussed in this section, the diagnosis of cataracts
is the major condition in Hiroshima (43.6% of the total) and the second most
prominent in Nagasaki (21.1% ). Since the prevalence ratios of cataracts to refrac-
tive abnormalities are markedly different in the two cities, it may be that a large
observational bias is, in fact, present.
Alternatively, it may be that neutrons, which contributed significantly to total
radiation exposure only in Hiroshima (9), are much more effective than gamma
radiation for the induction of cataract. A dose-dependent effectiveness for neutron
induction of lenticular abnormalities has been shown in experimental animals (32).
Studies now in progress concerning aging and visual acuity and accommodation
may yield further insight into eye conditions.
OTHER CONDITIONS
The survey of a decade of clinic examinations has uncovered a variety of other
radiation-related trends; some are statistically significant for a portion of the period
under discussion, others are suggestive. For instance, the prevalence of tuberculosis
was increased in males exposed to 100+ rad at age 20-29. This was not uniform
and occurred only during the second, third, and fifth cycles. Since healthy, mili-
tary-age males were notably absent from the civilian population (and accordingly
also from the ABCC clinical cohort), a bias in favor of less robust young persons
who were exposed to the A-bombs is probable.
For all other infective, parasitic, and degenerative diseases, there was no rela-
tionship with A-bomb radiation during 1958-1968.
Another aspect, which was reexamined with the new dosimetry, concerns growth
among persons exposed to high doses of A-bomb radiation. In general, these persons
seem shorter and lighter in weight at the completion of their growth period.
GROWTH AND DEVELOPMENT IN EXPOSED CHILDREN
For both cities and for both sexes, Fig. 3 shows shorter adult stature for the
subjects aged 0-19 who received 100+ rad ATB. The measurements used in the
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FIG. 3. Mean standing height, fifth examination cycle, by radiation dose, sex, and city,
age 0-19 ATB.
figure were made during the fifth cycle (1966-1968), at a time when the youngest
subjects were 21 years old. Significant differences (P < 0.01) are found only
for Hiroshima males; but an overall relation of diminished growth to A-bomb
seems clear. Additional analyses have shown that both male and female children
who were heavily irradiated in Hiroshima are, on the average, shorter adults (33).
The mean difference between those exposed at ages under 5 years to 100+ rad
compared with nonexposed children was about 4 cm (P < 0.001).
Observations regarding weight are similar. Especially in Hiroshima, males and
females show significantly (P < 0.001) lower body weight among those exposed
to 100+ rad when less than 20 years old.
Any explanation of growth differences must take into account possible growth
arresting factors, such as malnutrition, and the ages at which diets were nutrition-
ally deficient. In addition, physical and psychological stresses were certainly preva-
lent in wartime.
Deficient linear growth is reported for Marshall Island boys who were exposed
when they were less than 5 years old to radioactive fallout resulting from bomb
testing in 1954 (34). In these cases, hypothyroidism was presumably primarily
responsible. An association between thyroid dysfunction and exposure to the
A-bomb is under study at ABCC. However, it may be impossible to prove that
a total-body radiation effect on growth was mediated by thyroid disease.
A syndrome consisting of small stature, microcephaly, and mental retardation
has been reported among children who were exposed to A-bomb radiation while
in utero (23, 35, 36). Some growth retardation was also found among heavily
exposed children (37, 38), but the dose effect was estimated by distance. More
recent publications (39, 40) have strengthened these conclusions using dose esti-
mations to the mother. Our observation in conjunction with these other studies
seem to support the conclusion that the sensitivity of the child to radiation effects
on the growth process did not necessarily end at the moment of birth.
These conclusions on growth and development of heavily irradiated children are
strengthened when the evidence of suggestively smaller heart and thoracic diame-
ters among those aged 0-19 ATB who received high doses of radiation is revealed
in clinical screening (11). These measurements were made on standard X-rays
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TABLE 4
TRENDS AMONG A-BoMB SURVIVORS; 1958-68
ICD Changese with
Class classificationa Male/female Intercityb age Time
Tuberculosis 001-019 M > F H < N - Dec
Syphilis 020-029 H: M > F H < N Inc Dee
Parasitic diseases 1,0-138 N: M <F H < N - Dec
Diabetes 260 M > F M: H > N Inc Inc
Arteriosclerotic heart disease 420-422 M > F - Inc Inc
Hypertensive heart disease 440-443 - H < N Inc Inc
Diseases of blood 990-299 M < F - - Dec
Cholesterol M < F - - Inc
Glycosuria M > F H > N Inc Inc
Total WBC M>F - - Dec
"International Classification of Disease, 7th Revision.
6 H = Hiroshima; N = Nagasaki.
c Incidence: Inc = Increased; Dec = Decreased.
of the chest routinely obtained every biennium. In addition, somewhat lower blood
pressures have been recorded among heavily irradiated subjects.
CHANGES OVER TIME AND OTHER TRENDS
As a longitudinal population study, the current examination program has per-
sisted for 15 years at this writing.
It was not expected that for most observations during these years there would
be any very large trend in health status. Some of the changes which were noted
may be real, others may reflect trends in local medical practice or emphasis by
physicians with particular interests. Several observations show marked differences
between the cities of Hiroshima and Nagasaki. Some of these are listed in Table
4. In none of these items were irradiated persons at apparently greater risk.
DIABETES MELLITUS
The prevalence of diabetes mellitus increased sharply from Cycle 1 to Cycle
5 (Fig. 4), doubling in older people and increasing by an even larger factor in
those less than 40 years of age ATB. It is likely that there was more intensive
screening for diabetes after the early interest in the epidemiology and characteris-
tics of this disease in Japan (41-43).
200 - HIROSHIMA NAGASAKI
J MALE
m FEMALE
0
0
Li 100- z
1 2 3 4 5 1 2 3 4 5
CYCLE
FIG. 4. Prevalence of diabetes mellitus by cycle, sex, and city, age 40-49.
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The prevalence of this disease rose with age in both cities except in ages 50+
ATB.
Age-related diminishing glucose tolerance is well known, but this seems unable
to account for the steep increase with time noted here. Other factors that may
be important are changing diagnostic criteria, more intensive testing, and a gradual
dietary change to include Western foods.
Males, in both cities, showed higher rates than females throughout the five cycles
(Fig. 4). This difference would not be expected to be affected by changing diagnos-
tic effort or change in technique for glucose determination. Complications of
diabetes were not studied, but very few insulin-dependent cases were seen.
DISEASES OF BLOOD AND BLOOD-FORMING ORGANS
The major component of this group of conditions is Fe-deficient anemia. In
Hiroshima, changes in prevalence were not striking; however, in Nagasaki, espe-
cially among females, prevalence dropped very sharply from extraordinarily high
levels to a level comparable with Hiroshima. This may reflect the special interest
of investigators concerned with refractory and iron-deficiency anemia in Nagasaki
over the period 1959-1962, a decrease in intestinal infestation (shown by a parallel
decrease in ova and parasites in stool), and general improvement in diagnosis and
treatment in both communities.
SERUM CHOLESTEROL
The serum cholesterol values showed large increases from the first to the fifth
cycles-from mean levels of the order of 150-160 mg/100 ml to 170-190 mg/100
ml. This may reflect increased westernization of the diet.
In summary, A-bomb survivors health over the second decade after the bombs
seems to reflect expected findings in a country which had rapidly applied the benefits
of modern technology. Degenerative diseases, and particularly ischemic heart dis-
ease, have increased; diabetes and cholesterol levels have increased. Chronic
infectious and parasitic illnesses have decreased. Little clinically diagnosible impact
of A-bomb radiation is seen in specific entities except thyroid hyperplasia (simple
goiter). However, a somatic effect of radiation is noted in the shortened adult sta-
ture of those heavily irradiated in childhood. Neither heretofore unknown diseases
nor unusual manifestations of well-known conditions have been found.
MORTALITY AND CANCER
Since the ABCC study cohort is fixed, it can only age relentlessly; there is no
input of young persons. Deaths, especially in the older groups, continuously sub-
tracted subjects. However, the annual mortality rates in the examined group
showed no significant relationship to A-bomb radiation, nor was there a consistent
difference between Hiroshima and Nagasaki. Thus, we must look to studies other
than the routine clinic examinations for more details. The 5-fold larger population
sample (Life Span Study) of which the clinically examined group is a part does
reveal continuing increased mortality among heavily exposed persons (12). This
seems to be associated with deaths due to cancer, other than leukemia, and in
recent years is seen predominantly among those exposed at ages less than 10 years.
Since this finding is based on death certificates, confirmation must await correlation
between clinical observations and analysis of findings at autopsy.
It is of interest that cancer of the stomach, for which Japan ranks highest among
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developed countries (44), has not been found consistently increased among heavily
exposed survivors. One reason may be the high rate in controls which obscures
possible small differences due to radiation. More intensive case-finding studies are
now under way, based on epidemiologic evidence of higher risk in those with ab-
normalities in gastric acid and blood pepsinogen levels (45).
The absence of more definite findings may lie in the inability to diagnose all
conditions in the living subject, the large variability in accuracy of clinical examina-
tions which involved many physicians, and the long latent period for cancer.
ACCELERATION OF AGING
It has been difficult to come to grips with this provocative subject. Despite a
large body of experimental work which suggests that morbidity from nonspecific
causes is increased in irradiated animals, the design of an epidemiologic study
among humans is difficult. Hollingsworth et al. (46) studied age-related tests in
a small portion of the clinic group, and found no difference in responses of A-bomb
survivors compared to nonirradiated controls. These observations are currently be-
ing extended to the entire clinic sample of about 16,000 subjects.
Changes in physiologic function which differentiate normal persons from ir-
radiated survivors are sought. But whether the result can be properly called "pre-
mature aging" is debatable, and no clear hypotheses are agreed upon (47).
PSYCHOLOGIC AND SOCIAL SEQUELAE
These areas are the most elusive, and no definitive studies have been undertaken.
Of all the possible gauges of delayed effects of the atomic bomb, accurate measure-
ments regarding survivors' attitudes, habits, and fears are the most difficult to ob-
tain. Certainly, Americans cannot use their cultural preconceptions, or even lan-
guage, in a proper scientific enquiry among Japanese.
Regarding A-bomb survivors, Lifton (48) has written concerning a unique and
overwhelming encounter with death, and the aftermath of fear of late effects even
into future generations. His extensive insights are based on interviews with 75 per-
sons, of whom only 33 were selected from a list of 90,000 survivors. It is not
clear whether his conclusions apply to a larger portion of the population, and atti-
tudes measurable in large-scale surveys are needed.
On the other hand, there is evidence, by means of a self-administered question-
naire completed by about 12,000 members of the Adult Health Study group, that
exposed persons, even 20 years after the bombs, experienced more nonspecific
symptoms than nonexposed persons. The effect of this on their life patterns is not
known. As Lifton pointed out, the survivors have been made aware of radiation
effects by the news media and a variety of benevolent and political organizations.
Matsumoto (49) has gathered data that reflect patterns among the study popula-
tion which do not support some conceptions regarding suicide and marriage trends
among the survivors. Figures for 1950-1965 showed no higher rates for suicide
among heavily exposed compared with Japanese national vital statistics. The per-
centage of those who were not married 14 years after the bomb was no greater
among heavily exposed groups compared with lightly and nonexposed subjects.
This does not mean that there was no fear of marriage or genetic consequences,
or that survivors were able readily to find employment. Such surveys that have
been accomplished suggest only that there is no clear evidence of a significantly
affected life pattern.
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CYTOGENETIC STUDIES
Chromosome alterations consisting of dicentrics, ring forms, and breaks are in-
creased in heavily exposed survivors (50). Although these alterations seem to re-
flect a specific radiation effect (51), to date, no disease or functional abnormality
has been associated with these cytogenetic findings. Continued study, including
cloning of abnormal cells found in irradiated survivors, is part of the ongoing
program.
RELEVENCE TO THE PRESENT AND FUTURE
Controversy over the uses of technologic advances finds a major outlet in poten-
tial hazards of radiation. Japan, possibly at a greater rate than the United States
and other industrial nations, is building nuclear sources for power. To those con-
cerned with setting standards for radiation protection, the long-term consequences
of the atomic bombs are important and useful (52).
Examination and follow-up of Japanese who are still alive after experiencing
variable doses of A-bomb radiation provide a unique opportunity for the science
of health protection. Observations on cancer, accelerated aging, cytogenetic
changes, mutations in offspring, etc., must continue, at least for the lifetime of
the survivors.
Studies to date have shown that those irradiated during the period of rapid
growth and development-from conception to adolescence-appear to be most
susceptible to abnormalities. This knowledge is applicable to future health policies
among nations where radiation hazards will be an increasing by-product of
progress.
SUMMARY
Since 1958 a population of about 16,000 exposed and sex- and age-matched
nonexposed persons have been examined biennially at the Atomic Bomb Casualty
Commission in Hiroshima and Nagasaki, Japan, to judge late effects of A-bomb
radiation. The biennial checkups, in contrast to more probing studies with which
they are compared, have shown few radiation-related effects.
Screening examinations have revealed changes over time (1958-1968) in disease
patterns and certain intercity aspects. In this survey, those who experienced the
A-bomb disaster and survived seem generally to be as healthy as nonirradiated
persons, though risks for specific late effects cannot be dismissed, particularly
among those who were children at that time.
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